openPR Logo
Press release

Global Hormone Replacement Therapy Market Growth Analysis of all Top Key Players Like Bayer AG, Eli Lilly & Company, Roche, Abbott Laboratories and Others 2018 - 2023

11-28-2018 05:02 PM CET | Health & Medicine

Press release from: IMARC Group

Global Hormone Replacement Therapy Market Growth Analysis

The global hormone replacement therapy (HRT) market has witnessed a healthy growth in the recent years. This can be attributed to increasing hormonal disorders, technological advancements, rising awareness about the benefits of HRT among the consumers and escalating investment in R&D activities.

The latest report by IMARC Group, titled “Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, estimates that the global hormone replacement therapy market reached a value of around US$ 4 Billion in 2017. Hormone replacement therapy refers to a type of treatment which involves the management of low levels of hormones, resulting from lack of secretion in the human body. It is suitable for elderly patients suffering from hypogonadism, women in menopausal transition and patients with deficiency of growth hormone. HRT is considered to be a more efficacious treatment in comparison to its alternatives such as chemical drugs, herbal medicines, etc. However, there are some harmful effects of HRT such as indigestion, nausea, fluid retention, swelling, etc. Prolonged consumption of HRT drugs may also increase the risk of blood clots.

Get FREE Sample Report Before Buying @ https://www.imarcgroup.com/request?type=report&id=929&flag=B

Market Trends:

A rise in the prevalence of hormonal imbalance disorders in neonatal as well as elderly population is the major growth-inducing factor for the market. Apart from this, HRT is considered to be effective in treating the symptoms of menopause like night sweats, vaginal dryness, hot flashes and sexual function. Moreover, HRT helps in improving the quality of life and minimises the risk of cardiovascular diseases, colorectal cancer, vasomotor symptoms and osteoporosis. Further, advancements in technology, such as the introduction of transdermal drug delivery and new gel-based formulations, along with an increase in R&D investments by the manufacturers are providing a thrust to the market growth. Increasing awareness among the consumers, direct selling campaigns by the players, population aging and sedentary lifestyles are some of the other drivers boosting the demand for hormone replacement therapy. Looking forward, the market is projected to reach a value of nearly US$ 6 Billion by 2023, projecting a CAGR of 7.2% during 2018-2023.

Browse Full Report along with complete TOC @ https://www.imarcgroup.com/hormone-replacement-therapy-market

Market Summary:

The market has been segregated on the basis of product type into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy and testosterone replacement therapy. Amongst these, estrogen replacement therapy holds the largest market share.

Based on route of administration, parenteral represents the leading segment, accounting for the majority of the total market share. It is followed by oral and transdermal methods.

On the basis of disease, the report has divided the market into hypothyroidism, menopause, male hypogonadism and growth hormone deficiency. Currently, menopause accounts for the largest share.

Region-wise, North America represents the biggest market for hormone replacement therapy. It is followed by Europe, Asia Pacific, Middle East and Africa, and Latin America.

The report has also analyzed the competitive landscape of the market. Some of the key players include Bayer AG, Eli Lilly & Company, Roche, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Mylan, Novartis, Merck, Novo Nordisk and Pfizer.

Browse related reports:

Healthcare Information Software Market Research Report: https://www.imarcgroup.com/healthcare-information-software-market

Healthcare RCM Outsourcing Market Research Report: https://www.imarcgroup.com/healthcare-rcm-outsourcing-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Hormone Replacement Therapy Market Growth Analysis of all Top Key Players Like Bayer AG, Eli Lilly & Company, Roche, Abbott Laboratories and Others 2018 - 2023 here

News-ID: 1403941 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for HRT

United States Hormone Replacement Therapy (HRT) Market 2025 | Growth Drivers, Ke …
Market Size and Growth The Global Hormone Replacement Therapy (HRT) Market reached US$ 29.9 billion in 2024 and is expected to reach US$ 48.3 million by 2032, growing at a CAGR of 6.1% during the forecast period 2024-2033. Recent Mergers and Acquisitions : ✅ In July 2025, The HRT Club launched nationwide, providing access to a network of over 700 healthcare providers for hormone replacement therapies. ✅ In July 2025, Low T Center
Aging Population and Health Awareness Fuel the HRT Market
The Hormone Replacement Therapy Market Is Set To Grow At An Estimated CAGR Of 5.0% From 2025 To 2034, Rising From $25 Billion In 2024 To $40 Billion By 2034. On March 25, 2025, Exactitude Consultancy., Ltd. released a research report titled Hormone Replacement Therapy (HRT) Market 2025-2034 This report offers a new perspective on the Hormone Replacement Therapy (HRT) Market covering an extensive range of aspects including market overview, expenditure
Hormone Replacement Therapy (HRT) Market to Develop New Growth Story
The "Global Hormone Replacement Therapy (HRT)" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Global Hormone Replacement Therapy (HRT) provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures
Hormone Replacement Therapy (HRT) Market is Booming Worldwide | Pfizer, Novartis …
Allied Market Research Analyst have added a new research study on Title Hormone Replacement Therapy (HRT) Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), Merck KGaA, Mylan N.V. (Viatris Inc.), Novartis International AG, Novo Nordisk A/S, and Pfizer Inc. The Study provides in-depth
Global Hormone Replacement Therapy (HRT) Market By Route of Administration: Oral …
Global Hormone Replacement Therapy (HRT) Market to Reach USD 29.65 billion by 2028 According to the latest research by SkyQuest Technology, the Global Hormone Replacement Therapy (HRT) Market was valued at USD 14.98 billion in 2021, and it is expected to reach USD 29.65 billion by 2028, with a CAGR of 5.7% during the forecast period of 2022-2028. The research provides up-to-date Hormone Replacement Therapy (HRT) market analysis of the current
Hormone Replacement Therapy (HRT) Market Set to Witness Thriving Growth Worldwid …
Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body does not make them enough. For instance, hormone replacement therapy may be given to thyroid patients , menopause patients, several cancer patients, growth hormone deficiency patients etc. Furthermore, HRT was often administered to menopausal women for the relief of symptoms such as hot flushes, night sweats, sleep disturbances, psychological and genito-urinary disorders (urinary frequency